EUVIMEDEUVIMED entdecken
CrossrefInfokarte

A Retrospective Cohort Study Comparing Outcomes of Rubber Band Ligation in Grade II and III Hemorrhoids

Vipul D. Yagnik, Rajeshkumar Majithiya, Niteshkumar M. Patel, Prema Ram Choudhary

Indian Journal of Colo-Rectal Surgery · 2026-09 · 9 (3) · 194-198

DOI: 10.4103/ijcs.ijcs_31_26 ↗
AbstractBibliografische Angaben

Abstract

A BSTRACT Background: Rubber band ligation (RBL) is recommended as first-line therapy for Grade II and selected Grade III hemorrhoids; however, real-world data comparing outcomes across grades remain limited. This study aims to evaluate the effectiveness and safety of RBL in Grade II and III hemorrhoids and assess whether outcomes differ between grades. Methods: Retrospective cohort study conducted at a specialized center between January 2022 and December 2024, including 100 consecutive adult patients with Grade II–III internal hemorrhoids. Outpatient RBL using a Barron ligator was performed for Grade II and Grade III hemorrhoids. The primary outcome was complete symptom resolution. Secondary outcomes included complications and recurrence at 6 months. Statistical comparison between grades was performed. Results: At 6 months, complete symptom resolution was achieved in 35/38 Grade II patients (92.1%) and 55/62 Grade III patients (88.7%) ( P = 0.585). Recurrence rates at 6 months were 7.9% (Grade II) and 11.3% (Grade III) ( P > 0.05). Retreatment was required in 7.9% and 11.3%, respectively ( P > 0.05). Postprocedural pain (Visual Analog Scale ≥4) occurred in 21.1% (Grade II) and 25.8% (Grade III). Overall complication rates were low and similar (7.9% vs. 8.1%; P > 0.05). No major complications (e.g., transfusion, sepsis, and anal stenosis) were recorded. Conclusion: Three-band RBL is a safe and effective outpatient treatment for both Grade II and Grade III internal hemorrhoids, providing comparable symptom resolution, low recurrence, and minimal complications at 6 months. Larger prospective studies with longer follow-up are recommended to confirm long-term durability.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →